(S)-WAY-100135

(+)-WAY 100135

(2S)-3-[4-(2-Methoxyphenyl)-1-piperazinyl]-N-(2-methyl-2-propanyl)-2-phenylpropanamid

(2S)-3-[4-(2-Methoxyphenyl)-1-piperazinyl]-N-(2-methyl-2-propanyl)-2-phenylpropanamide

(2S)-3-[4-(2-Méthoxyphényl)-1-pipérazinyl]-N-(2-méthyl-2-propanyl)-2-phénylpropanamide

(S)-WAY-100135

1-Piperazinepropanamide, N-(1,1-dimethylethyl)-4-(2-methoxyphenyl)-alpha-phenyl-, (alphaS)-

(2S)-N-tert-butyl-3-[4-(2-methoxyphenyl)piperazin-1-yl]-2-phenylpropanamide

(S)-N-tert-Butyl-3-(4-(2-methoxy-phenyl)-piperazin-1-yl)-2-phenylpropanamide

133025-23-7

149007-54-5

5-hydroxytryptamine receptor 1A

5-hydroxytryptamine receptor 1B

5-hydroxytryptamine receptor 1D

5-hydroxytryptamine receptor 2A

5-hydroxytryptamine receptor 2C

5-hydroxytryptamine receptor 3A

5HT1A_HUMAN

5HT1A_RAT

5HT1B_RAT

5HT2A_RAT

5HT3A_RAT

A0A1V4J3K6_PATFA

A0A1V4J4E5_PATFA

A0A1V4J7Y5_PATFA

A0A1V4JDN9_PATFA

A0A1V4JMG2_PATFA

A0A1V4KJJ8_PATFA

A0A1V4KRM0_PATFA

A0A1V4KYG9_PATFA

A0A218UVI3_9PASE

D(2) dopamine receptor

D(3) dopamine receptor

G7ZKZ7_PIG

MFCD00923003

N-tert-Butyl-3-[4-(2-methoxy-phenyl)-piperazin-1-yl]-2-phenyl-propionamide

WAY 100,135

α-1A adrenergic receptor